Chetan Wazekar undergoes renal denervation for resistant hypertension in Navi Mumbai
- Chetan Wazekar, a 42-year-old biker, suffered from resistant hypertension, experiencing severe symptoms that affected his daily life.
- He underwent a successful renal denervation procedure at Apollo Hospitals in Navi Mumbai, which disrupts nerve signals contributing to high blood pressure.
- Post-procedure, Wazekar reported feeling like a new person, with his blood pressure under control and a renewed enthusiasm for life.
Chetan Wazekar, a 42-year-old biker from Navi Mumbai, faced severe health issues due to resistant hypertension, which persisted despite multiple antihypertensive medications. His symptoms included blurred vision, dizziness, palpitations, headaches, and shortness of breath, significantly impacting his daily life and increasing his risk for serious health complications such as heart attacks and stroke. Dr. Brajesh Kunwar, a Senior Interventional Cardiologist at Apollo Hospitals, recommended renal denervation as a last resort to manage Wazekar's condition effectively. On August 23, Wazekar underwent a successful renal denervation procedure, a minimally invasive technique that disrupts sympathetic nerve signals contributing to high blood pressure. This procedure is particularly beneficial for patients like Wazekar, who do not respond well to conventional treatments. The doctor noted that resistant hypertension affects 10% to 20% of patients with hypertension, and timely intervention is crucial for young patients to prevent severe health implications. Post-procedure, Wazekar reported a significant improvement in his health, stating he felt like a new person with his blood pressure under control. He expressed excitement about returning to his active lifestyle without the constant fear of health complications. The success of this procedure highlights the potential of renal denervation as a promising option for long-term blood pressure management. Dr. Kunwar emphasized that while this technique is currently recommended only for adults with resistant hypertension, there is hope that it may become a first-line treatment in the future, reducing the dependency on medication for managing high blood pressure.